LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Medlab Middle East Sees 100% Increase in Exhibitor Numbers

By LabMedica International staff writers
Posted on 16 Jan 2023
The focus on technology and sustainability has seen unprecedented demand from exhibitors (Photo courtesy of Informa Markets)
The focus on technology and sustainability has seen unprecedented demand from exhibitors (Photo courtesy of Informa Markets)

Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress, has sold out its exhibitor space ahead of the show, which returns to the Dubai World Trade Centre from February 6 to 9, 2023.

The latest statistics from the Medlab Middle East organizer, Informa Markets (London, UK), reveal that the number of exhibition halls is up from four to six, with a total of 31,000 sq. mt. of space. Over 350 new exhibitors have been confirmed, taking the total to more than 700, with 180 countries represented, marking a 100% increase as compared to the 2022 edition of the show. Additionally, international pavilions have also increased from 11 to 14.

In line with the Medlab Middle East theme, ‘paving the way for technological advancements and sustainability in laboratory medicine’, various exhibitors will showcase their latest products in fields such as disposables, imaging, IT systems, and medical equipment, among others, contributing to the rise in exhibitor numbers. Apart from a full line-up of exhibitors on the show floor, Medlab Middle East will launch its Hosted Buyer program, which will match exhibitors with senior decision-makers belonging to the healthcare industry. The show floor will also offer a series of seminars and workshops to allow visitors to learn first-hand about the latest medical laboratory innovations from the exhibitors.

At Medlab Middle East, the newly-launched Labpreneur competition will invite promising diagnostic start-up companies to pitch groundbreaking ideas that can transform the laboratory market to a panel of experts who will select the winner on the final day of the exhibition. This year, the Medlab Middle East Congress will also return, providing education and solutions to advance laboratory skills and improve laboratory functions to over 5,000 conference delegates. With 12 conferences, the Congress is the largest CME-accredited multi-track medical laboratory congress in the world, featuring 130+ local and international speakers. This year's conference program will include eight core lab conference tracks, with further four new additions addressing Point of Care Testing (POCT), Tech Advances and Clinical Impact, New trends in laboratory medicine, Quality Management in the Lab, and Sustainability in the Lab. For the first time, Medlab Middle East will showcase a new Entertainment zone – The Village, which will provide a more relaxed environment to the attendees for networking.

“It has been an incredible year of growth for the medical laboratory industry and Medlab Middle East. This year we will welcome 650 exhibitors from 180 countries, many of whom are making their debut at the event by highlighting the latest technological advances on the market,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare. “We are also welcoming back several of our Asian counterparts who have been unable to travel due to restrictions in their home countries as well as stalwarts of the event Abbott, Biomerieux, Beckman Coulter, Randox, illumina, bioMérieux, Randox and Mindray, amongst others.”

 

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more